How to Submit to JAMA: Step-by-Step Guide (2026)

JAMA is the Journal of the American Medical Association , one of the four most-cited medical journals in the world alongside NEJM, The Lancet, and BMJ. Its IF of 55.0 and ~5% acceptance rate place it among the most selective clinical journals.

The submission process is specific and unforgiving about formatting. Papers that arrive incorrectly formatted are returned before any editorial review. Here's how to get it right.

Decide: JAMA or a JAMA Network Journal?

Before submitting to JAMA itself, confirm that the flagship journal is the right target. JAMA Network publishes specialty journals with overlapping scope but more focused readership:

• JAMA Internal Medicine: high-quality clinical research in internal medicine and primary care, IF 23.3
• JAMA Cardiology: cardiovascular clinical research, IF 14.1
• JAMA Oncology: clinical oncology, IF 20.1
• JAMA Neurology: clinical neurology, IF 21.3
• JAMA Network Open: open-access, broader scope, IF 9.7

If your clinical trial is primarily of interest to cardiologists, JAMA Cardiology is often the more efficient target , the scope is right, the review process is familiar, and the IF is still strong. Submitting subspecialty work to JAMA itself means competing against papers with broader public health implications, which puts you at a disadvantage at the desk.

Target JAMA when:

• The findings affect clinical practice across multiple specialties
• The public health or policy implications are national or international in scope
• The study addresses a question that general internists and primary care physicians encounter regularly

Formatting Requirements for Original Investigations

JAMA's formatting requirements for original research (as of 2026 , verify current guidelines before submitting):

• Main text: 3,000 words maximum (excluding abstract, references, figures, tables)
• Abstract: 350 words maximum, structured (Importance, Objective, Design/Setting/Participants, Interventions, Main Outcomes and Measures, Results, Conclusions and Relevance)
• Tables and figures: 4 combined maximum for most article types
• References: limited to 30 for original investigations; use Vancouver format
• Required reporting checklist: CONSORT for RCTs, STROBE for observational studies, PRISMA for systematic reviews , must be uploaded as a separate file
• Statistical analysis plan: should be described sufficiently to allow replication

The abstract structure is worth noting: "Main Outcomes and Measures" is JAMA's terminology for what most journals call the primary endpoint. "Conclusions and Relevance" replaces "Conclusions" , the relevance to clinical practice is expected explicitly.

The Cover Letter

JAMA's editors read the cover letter as the first filter. It should:

Lead with the finding: One sentence stating the primary result with a specific number. "In this trial of [N] patients with [condition], [treatment] reduced [primary endpoint] by [X]% compared to [control] (HR 0.78; 95% CI 0.68-0.89; p<0.001)."

State clinical and public health relevance: Two to three sentences on why this matters for patient care and who is affected. Be specific about population size: "[Condition] affects [X] million Americans annually, and current treatment options have [specific limitation]."

Establish journal fit: One sentence on why JAMA specifically , not a specialty journal. "We believe these findings are relevant to all physicians who manage [condition], including primary care physicians who constitute a core JAMA readership."

Confirm compliance: One paragraph: all authors approved, no competing interests (or list them), the paper hasn't been submitted elsewhere, required checklists are attached.

Keep the cover letter under one page , 300-400 words is ideal.

Statistical Requirements

JAMA's statistics team reviews every paper that clears the desk. The most common statistical issues flagged:

1. P-value reporting without effect sizes: JAMA requires effect sizes and confidence intervals, not just p-values
2. Missing multiplicity adjustments: If you tested multiple endpoints, explain how you controlled for multiple comparisons
3. Incomplete sample size calculation: Report the assumptions used in your power calculation
4. Selective reporting: If you had prespecified secondary endpoints, report all of them , not just the ones that were significant
5. Missing data handling: Report the extent of missing data and how you handled it (imputation method, sensitivity analyses)

Addressing these proactively in the methods section reduces the chance of a statistics-related rejection at peer review.

Common Reasons for JAMA Desk Rejection

• Scope mismatch: clinical research primarily of interest to one subspecialty
• Insufficient clinical or public health significance: well-executed but incremental findings
• Retrospective single-center design where prospective multicenter data is feasible
• Missing required checklists (administrative return before editorial review)
• Word count over the limit (3,000 for original investigations)
• Randomized trial not registered in an approved registry before enrollment

The Statistical and Peer Review Process

Papers that clear the desk go to 2-3 external peer reviewers plus JAMA's internal statistician. Reviewer selection takes 1-2 weeks; active review takes 4-8 weeks.

JAMA's peer reviewers are typically senior clinicians and methodologists. Expect detailed feedback on:

• Clinical significance of the effect size (not just statistical significance)
• Generalizability of your findings to the populations physicians actually treat
• Completeness of subgroup analyses for major demographic groups
• Adequacy of sensitivity analyses for key assumptions

Common Mistakes to Avoid

Most authors lose time in this topic for one reason: they optimize the wrong variable first. They spend hours polishing language while leaving structural issues unresolved. Editors and reviewers evaluate structure before style.

In practice, the recurring mistakes are predictable:

1. Using generic claims instead of specifics. Replace vague statements with concrete numbers, study details, and explicit scope boundaries.
2. Ignoring fit and audience. A strong manuscript sent to the wrong journal or framed for the wrong reader still fails quickly.
3. Treating revision as proofreading. Revision is where argument quality, methodological clarity, and limitation handling should improve meaningfully.
4. Skipping process checks. Formatting, references, checklist compliance, and data statements look administrative, but they're part of editorial quality control.

A useful rule is to run one final pre-submission pass that checks only these operational risks: scope fit, claim strength, methods clarity, and policy compliance. That pass catches most avoidable rejection reasons before they become reviewer comments.

If you're deciding between two valid options, pick the one that improves clarity for an external reader who has no context besides your paper. Clearer framing beats denser writing almost every time.

Practical Checklist Before You Act

Use this short checklist right before submission or journal targeting:

• Scope check (2 minutes): Can you explain in one sentence why this exact journal is the right reader audience?
• Claim check (3 minutes): Does each major claim map directly to a result already shown in the manuscript?
• Methods check (3 minutes): Could an external reviewer reproduce your approach from what is written now?
• Limitations check (2 minutes): Are the real constraints stated plainly instead of hidden in soft wording?
• Decision check (2 minutes): If this is rejected at desk, do you already know your next-best journal target?

Most delays in publication come from skipping this simple operational pass. Authors often discover after rejection that the science was acceptable but the framing, scope alignment, or reporting completeness was not. Running this checklist before submission reduces that avoidable risk.

For teams, make one person responsible for this pass. Shared ownership usually means nobody does it thoroughly. A single owner with final sign-off keeps quality control consistent across projects.

JAMA's Conflict of Interest Policy

JAMA has one of the most stringent conflict of interest disclosure policies among clinical journals. All authors must disclose any financial relationships with companies whose products are studied in the manuscript, any financial relationships with competing companies, and any other relevant conflicts.

The disclosure applies to the past 36 months, not just the time of the study. Authors who received speaker fees, consulting payments, advisory board compensation, or equity in a relevant company must disclose these even if the study itself was conducted independently.

JAMA's editors take undisclosed conflicts seriously. Several high-profile papers have been retracted or subjected to editorial notes for undisclosed conflicts discovered after publication. When in doubt, disclose.

The cover letter should include a conflicts of interest summary statement, even if the detailed ICMJE forms are submitted separately.

Responding to the Statistical Reviewer

If your paper clears JAMA's desk, it will receive statistical review in addition to clinical peer review. The statistical reviewer is a separate independent reviewer, not one of the clinical specialists.

Statistical reviewers at JAMA typically assess:

• Sample size and power calculation adequacy
• Primary endpoint prespecification vs. post-hoc
• Multiple comparison correction where applicable
• Missing data handling (imputation vs. complete case)
• Subgroup analysis pre-specification
• Time-to-event analysis quality (log-rank tests, Cox models)

Addressing these clearly in the methods section reduces the statistical reviewer's workload and the scope of revision requests. A methods section that clearly states your statistical analysis plan, explains how missing data was handled, and identifies which subgroup analyses were prespecified is far less likely to generate a full page of statistical comments than one that leaves these questions unanswered.

The Bottom Line

JAMA requires precise formatting, specific reporting checklists, and clear clinical and public health significance. Papers that arrive formatted correctly, with complete disclosures, targeting the right scope level, have a real chance at clearing the desk. Papers that arrive with missing checklists, over the word limit, or addressing a primarily subspecialty question don't , regardless of the science. Get the logistics right before the editorial process even begins.

See also

• JAMA acceptance rate 2026
• JAMA impact factor 2026
• NEJM submission guide

• JAMA journal profile

Sources

• JAMA author instructions (jamanetwork.com/journals/jama/pages/Instructions-for-Authors)
• CONSORT checklist (consort-statement.org)
• STROBE checklist (strobe-statement.org)
• Pre-Submission Checklist